Chemtura (NYSE: CHMT) reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $399 million versus the consensus estimate of $424.81 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.